COMPARISON OF CNS-RELATED SUBJECTIVE SYMPTOMS IN HYPERTENSIVE PATIENTS TREATED WITH EITHER A NEW CONTROLLED RELEASE (CR ZOK) FORMULATION OF METOPROLOL OR ATENOLOL

被引：12

作者：

DIMENAS, E

OSTERGREN, J

LINDVALL, K

DAHLOF, C

WESTERGREN, G

DEFAIRE, U

机构：

[1] AB HASSLE,CARDIOVASC RES,S-43183 MOLNDAL,SWEDEN

[2] SAHLGRENS UNIV HOSP,DEPT CLIN PHARMACOL,S-41345 GOTHENBURG,SWEDEN

[3] KAROLINSKA INST,DANDERYD HOSP,DEPT MED,DANDERYD,SWEDEN

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1990年 / 30卷 / 02期

关键词：

D O I：

10.1002/j.1552-4604.1990.tb03502.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S82 / S90

页数：9

共 27 条

[11] LIPID-SOLUBLE AND WATER-SOLUBLE BETA-BLOCKERS - COMPARISON OF THE CENTRAL-NERVOUS-SYSTEM DEPRESSANT EFFECT [J].

GENGO, FM ;

HUNTOON, L ;

MCHUGH, WB .

ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (01) :39-43

[12]

HALEY RJ, 1984, CURR THER RES CLIN E, V36, P993

[13] EFFECTS ON EXERCISE TACHYCARDIA DURING 48 HOURS OF A SERIES OF DOSES OF ATENOLOL, SOTALOL, AND METOPROLOL [J].

HARRON, DWG ;

BALNAVE, K ;

KINNEY, CD ;

WILSON, R ;

RUSSELL, CJ ;

SHANKS, RG .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (03) :295-302

[14]

HJALMARSON A, 1983, CIRCULATION S1, V67, P126

[15]

KIRK CA, 1983, POSTGRAD MED J, V59, P161

[16]

KOELLA WP, 1985, EUR J CLIN PHARMACOL, V28, pS55

[17] CENTRAL-NERVOUS-SYSTEM EFFECTS OF BETA-ADRENERGIC-BLOCKING DRUGS - THE ROLE OF ANCILLARY PROPERTIES [J].

KOSTIS, JB ;

ROSEN, RC .

CIRCULATION, 1987, 75 (01) :204-212

[18] CENTRAL EFFECTS OF BETA-ADRENOCEPTOR ANTAGONISTS .2. ELECTROENCEPHALOGRAM AND BODY SWAY [J].

NICHOLSON, AN ;

WRIGHT, NA ;

ZETLEIN, MB ;

CURRIE, D ;

MCDEVITT, DG .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 26 (02) :129-141

[19] LONG-TERM TREATMENT WITH METOPROLOL AFTER MYOCARDIAL-INFARCTION - EFFECT ON 3-YEAR MORTALITY AND MORBIDITY [J].

OLSSON, G ;

REHNQVIST, N ;

SJOGREN, A ;

ERHARDT, L ;

LUNDMAN, T .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (06) :1428-1437

[20] DEVELOPMENT OF A NEW CONTROLLED RELEASE METOPROLOL PRODUCT [J].

RAGNARSSON, G ;

SANDBERG, A ;

JONSSON, UE ;

SJOGREN, J .

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1987, 13 (9-11) :1495-1509

← 1 2 3 →